| 1 |
33587348 | LncRNA highly upregulated in liver cancer regulates imatinib resistance in chronic myeloid leukemia via the miR-150-5p/MCL1 axis. | 2021 Apr 1 |
3 |
| 2 |
34564697 | Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells. | 2021 Sep 25 |
1 |
| 3 |
32999756 | Expression differences of miR-142-5p between treatment-naïve chronic myeloid leukemia patients responding and non-responding to imatinib therapy suggest a link to oncogenic ABL2, SRI, cKIT and MCL1 signaling pathways critical for development of therapy resistance. | 2020 |
1 |
| 4 |
30866043 | Neferine in the Lotus Plumule Potentiates the Antitumor Effect of Imatinib in Primary Chronic Myeloid Leukemia Cells In Vitro. | 2019 Apr |
1 |
| 5 |
31349760 | The NEDD8-activating enzyme inhibitor MLN4924 induces DNA damage in Ph+ leukemia and sensitizes for ABL kinase inhibitors. | 2019 Sep |
1 |
| 6 |
30205168 | Hydroxycoumarin OT-55 kills CML cells alone or in synergy with imatinib or Synribo: Involvement of ER stress and DAMP release. | 2018 Dec 1 |
1 |
| 7 |
28319085 | Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions. | 2017 May |
1 |
| 8 |
26473951 | Knockout Serum Replacement Promotes Cell Survival by Preventing BIM from Inducing Mitochondrial Cytochrome C Release. | 2015 |
1 |
| 9 |
24088895 | Activin A induction of erythroid differentiation sensitizes K562 chronic myeloid leukemia cells to a subtoxic concentration of imatinib. | 2014 Jan 1 |
1 |
| 10 |
24947165 | Anti-apoptotic effects of osteopontin through the up-regulation of Mcl-1 in gastrointestinal stromal tumors. | 2014 Jun 20 |
2 |
| 11 |
23613979 | Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation. | 2013 |
1 |
| 12 |
22033489 | Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitors. | 2012 Apr |
1 |
| 13 |
21195056 | Bortezomib and sphingosine kinase inhibitor interact synergistically to induces apoptosis in BCR/ABl+ cells sensitive and resistant to STI571 through down-regulation Mcl-1. | 2011 Feb 4 |
1 |
| 14 |
21220745 | c-Abl regulates Mcl-1 gene expression in chronic lymphocytic leukemia cells. | 2011 Feb 24 |
1 |
| 15 |
20153728 | Spred2 is involved in imatinib-induced cytotoxicity in chronic myeloid leukemia cells. | 2010 Mar 19 |
1 |
| 16 |
17110460 | Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412. | 2007 Apr 1 |
1 |
| 17 |
17595328 | The multikinase inhibitor sorafenib induces apoptosis in highly imatinib mesylate-resistant bcr/abl+ human leukemia cells in association with signal transducer and activator of transcription 5 inhibition and myeloid cell leukemia-1 down-regulation. | 2007 Sep |
1 |
| 18 |
17926190 | (-)Gossypol and its combination with imatinib induce apoptosis in human chronic myeloid leukemic cells. | 2007 Nov |
1 |
| 19 |
18088462 | [STI571 induces apoptosis of K562 cells through down-regulation of anti-apoptotic protein Mcl-1 and Bcl-xl expression]. | 2007 Dec |
3 |
| 20 |
15626746 | Identification of mcl-1 as a BCR/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. | 2005 Apr 15 |
4 |
| 21 |
11782377 | Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells. | 2002 Jan 1 |
1 |
| 22 |
12231544 | Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells. | 2002 Sep |
1 |